HR-5585 : Still Just a Bill

Advanced Research Project Agency-Health Act or the ARPA-H Act

This bill establishes within the Department of Health and Human Services (HHS) the Advanced Research Projects Agency-Health to accelerate innovation in health and medicine by investing in high-risk, high-reward research projects. The bill also establishes an interagency committee to inform, and a fund in the Treasury to support, the agency's activities.

The President must appoint from the personnel of HHS a director to lead the agency. The director may submit testimony and recommendations concerning the agency to Congress without review or approval by other federal officers or agencies.

The director must designate personnel to serve as program managers who administer the agency's research programs, including by selecting projects to support, setting progress milestones for projects, and making recommendations about terminating or continuing projects.

The agency may use a variety of mechanisms to support the research projects, including grants, contracts, and prize competitions. The agency's budget is separate from that of HHS.

The agency must coordinate with the Food and Drug Administration and the Centers for Medicare & Medicaid Services to expedite development and coverage of high-need cures. Additionally, the agency may partner with other public and private entities, such as institutions of higher education and patient advocacy organizations.

The bill also requires the agency to develop and periodically update a strategic plan and annually report on its activities. Furthermore, the National Academies of Sciences, Engineering, and Medicine must evaluate the agency's performance.

Action Timeline

Action DateTypeTextSource
2022-06-23IntroReferralReceived in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.Senate
2022-06-22FloorMotion to reconsider laid on the table Agreed to without objection.House floor actions
2022-06-22VoteOn passage Passed by the Yeas and Nays: 336 - 85 (Roll no. 288).House floor actions
2022-06-22FloorConsidered as unfinished business. (consideration: CR H5808-5809)House floor actions
2022-06-22FloorPursuant to clause 1(c) of rule XIX, the Chair announced that further proceedings on H.R. 5585 would resume.House floor actions
2022-06-22FloorPursuant to clause 1(c) of rule XIX, the Chair announced that further proceedings on H.R. 5585 would be postponed.House floor actions
2022-06-22FloorPOSTPONED PROCEEDINGS - At the conclusion of debate on the Eshoo amendment, the Chair put the question on adoption of the amendment and by voice vote, announced that the ayes had prevailed. Mrs. Boebert demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced.House floor actions
2022-06-22FloorDEBATE - Pursuant to the provisions of H. Res. 1170, the House proceeded with 10 minutes of debate on the Eshoo amendment No. 1.House floor actions
2022-06-22FloorDEBATE - The House proceeded with one hour of debate on H.R. 5585.House floor actions
2022-06-22FloorRule provides for consideration of H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides for one hour of general debate on H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides for one motion to recommit each for H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides that proceedings may be postponed through July 15, 2022, on measures that were the object of motions to suspend the rules on the legislative days of June 21, 2022, June 22, 2022, June 23, 2022, or June 24, 2022, and on which the yeas and nays were ordered.House floor actions
2022-06-22FloorConsidered under the provisions of rule H. Res. 1191. (consideration: CR H5795-5803; text: CR H5795-5798)House floor actions
2022-06-21FloorRules Committee Resolution H. Res. 1191 Reported to House. Rule provides for consideration of H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides for one hour of general debate on H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides for one motion to recommit each for H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides that proceedings may be postponed through July 15, 2022, on measures that were the object of motions to suspend the rules on the legislative days of June 21, 2022, June 22, 2022, June 23, 2022, or June 24, 2022, and on which the yeas and nays were ordered.House floor actions
2022-06-13CalendarsPlaced on the Union Calendar, Calendar No. 277.House floor actions
2022-06-13CommitteeReported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-365.House floor actions
2022-05-18CommitteeOrdered to be Reported (Amended) by the Yeas and Nays: 53 - 3.House committee actions
2022-05-18CommitteeCommittee Consideration and Mark-up Session Held.House committee actions
2022-05-11CommitteeForwarded by Subcommittee to Full Committee by Voice Vote .House committee actions
2022-05-11CommitteeSubcommittee Consideration and Mark-up Session Held.House committee actions
2021-10-18CommitteeReferred to the Subcommittee on Health.House committee actions
2021-10-15IntroReferralReferred to the House Committee on Energy and Commerce.House floor actions
2021-10-15IntroReferralIntroduced in HouseLibrary of Congress

Sponsor :

Rep. Eshoo, Anna G. [D-CA-18]
See Cosponsors

Policy Area :

Health
See Subjects
  • Advisory bodies
  • Department of Health and Human Services
  • Drug safety, medical device, and laboratory regulation
  • Executive agency funding and structure
  • Federal officials
  • Government information and archives
  • Government studies and investigations
  • Health care costs and insurance
  • Health technology, devices, supplies
  • Public contracts and procurement
  • Research administration and funding
  • Research and development
  • Technology transfer and commercialization

Related Bills

See Related Bills